Abstract:Human brain organoids are emerging models to study human brain development and pathology as they recapitulate the development and characteristics of major neural cell types, and enable manipulation through an in vitro system. Over the past decade, with the advent of spatial technologies, mass spectrometry imaging (MSI) has become a prominent tool for metabolic microscopy, providing label-free, non-targeted molecular and spatial distribution information of the metabolites within tissue, including lipids. This technology has never been used for studies of brain organoids and here, we set out to develop a standardized protocol for preparation and mass spectrometry imaging of human brain organoids. We present an optimized and validated sample preparation protocol, including sample fixation, optimal embedding solution, homogenous deposition of matrices, data acquisition and processing to maximize the molecular information derived from mass spectrometry imaging. We focus on lipids in organoids, as they play critical roles during cellular and brain development. Using high spatial and mass resolution in positive- and negative-ion modes, we detected 260 lipids in the organoids. Seven of them were uniquely localized within the neurogenic niches or rosettes as confirmed by histology, suggesting their importance for neuroprogenitor proliferation. We observed a particularly striking distribution of ceramide-phosphoethanolamine CerPE 36:1; O2 which was restricted within rosettes and of phosphatidyl-ethanolamine PE 38:3, which was distributed throughout the organoid tissue but not in rosettes. This suggests that ceramide in this particular lipid species might be important for neuroprogenitor biology, while its removal may be important for terminal differentiation of their progeny. Overall, our study establishes the first optimized experimental pipeline and data processing strategy for mass spectrometry imaging of human brain organoids, allowing direct comparison of lipid signal intensities and distributions in these tissues. Further, our data shed new light on the complex processes that govern brain development by identifying specific lipid signatures that may play a role in cell fate trajectories. Mass spectrometry imaging thus has great potential in advancing our understanding of early brain development as well as disease modeling and drug discovery.

Single-cell mapping of lipid metabolites using an infrared probe in human-derived model systems

Lipid Metabolic Heterogeneity During Early Embryogenesis Revealed by Hyper-3D Stimulated Raman Imaging

Spatial Sterol Metabolism Unveiled by Stimulated Raman Imaging

In Situ Lipid Profiling at Submicron Resolution by Hyperspectral Stimulated Raman Imaging

Mapping Metabolic Changes by Noninvasive, Multiparametric, High-Resolution Imaging Using Endogenous Contrast.

Multiparametric, Label-Free Two-Photon Imaging of Metabolic Function (conference Presentation)

Multi-modal, Label-free, Optical Mapping of Cellular Metabolic Function and Oxidative Stress in 3D Engineered Brain Tissue Models

Large-Scale Modeling Approach Reveals Functional Metabolic Shifts during Hepatic Differentiation

Mass spectrometry imaging as an emerging tool for studying metabolism in human brain organoids

In Vivo Metabolic Fingerprinting of Neutral Lipids with Hyperspectral Stimulated Raman Scattering Microscopy.

Multi-Molecular Hyperspectral PRM-SRS Imaging

All-Optical Multimodal Mapping of Single Cell Type-Specific Metabolic Activities via REDCAT

Multiplex stimulated Raman scattering imaging cytometry reveals cancer metabolic signatures in a spatially, temporally, and spectrally resolved manner

Quantitative imaging of species-specific lipid transport in mammalian cells

C-SpaceM: Spatial single-cell isotope tracing reveals heterogeneity of fatty acid synthesis in cancer

Modeling Compound Lipid Homeostasis Using Stable Isotope Tracing

Photostable fluorescent probes for 3D imaging and monitoring the metabolism of lipid droplets

Bioorthogonal Chemical Imaging of Metabolic Activities in Live Mammalian Hippocampal Tissues with Stimulated Raman Scattering.

Multi-molecular hyperspectral PRM-SRS microscopy

The 3D OrbiSIMS-label-free metabolic imaging with subcellular lateral resolution and high mass-resolving power

Single Cell Proteome Mapping of Tissue Heterogeneity Using Microfluidic Nanodroplet Sample Processing and Ultrasensitive LC-MS.